1. Home
  2. TRVI vs MCFT Comparison

TRVI vs MCFT Comparison

Compare TRVI & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • MCFT
  • Stock Information
  • Founded
  • TRVI 2011
  • MCFT 1968
  • Country
  • TRVI United States
  • MCFT United States
  • Employees
  • TRVI N/A
  • MCFT N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • MCFT Marine Transportation
  • Sector
  • TRVI Health Care
  • MCFT Industrials
  • Exchange
  • TRVI Nasdaq
  • MCFT Nasdaq
  • Market Cap
  • TRVI 341.4M
  • MCFT 307.5M
  • IPO Year
  • TRVI 2019
  • MCFT 2015
  • Fundamental
  • Price
  • TRVI $4.24
  • MCFT $17.98
  • Analyst Decision
  • TRVI Strong Buy
  • MCFT Buy
  • Analyst Count
  • TRVI 8
  • MCFT 4
  • Target Price
  • TRVI $9.31
  • MCFT $20.75
  • AVG Volume (30 Days)
  • TRVI 454.6K
  • MCFT 62.1K
  • Earning Date
  • TRVI 03-19-2025
  • MCFT 02-06-2025
  • Dividend Yield
  • TRVI N/A
  • MCFT N/A
  • EPS Growth
  • TRVI N/A
  • MCFT N/A
  • EPS
  • TRVI N/A
  • MCFT N/A
  • Revenue
  • TRVI N/A
  • MCFT $337,642,000.00
  • Revenue This Year
  • TRVI N/A
  • MCFT N/A
  • Revenue Next Year
  • TRVI N/A
  • MCFT $15.63
  • P/E Ratio
  • TRVI N/A
  • MCFT N/A
  • Revenue Growth
  • TRVI N/A
  • MCFT N/A
  • 52 Week Low
  • TRVI $1.39
  • MCFT $16.12
  • 52 Week High
  • TRVI $4.68
  • MCFT $24.05
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 60.00
  • MCFT 42.56
  • Support Level
  • TRVI $3.81
  • MCFT $17.47
  • Resistance Level
  • TRVI $4.04
  • MCFT $19.15
  • Average True Range (ATR)
  • TRVI 0.25
  • MCFT 0.58
  • MACD
  • TRVI -0.00
  • MCFT -0.01
  • Stochastic Oscillator
  • TRVI 90.89
  • MCFT 29.14

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About MCFT MasterCraft Boat Holdings Inc.

MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.

Share on Social Networks: